Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/105637
Title: An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography
Authors: Wang, L.-Z. 
Goh, B.-C.
Lee, H.-S.
Noordhuis, P.
Peters, G.J.
Keywords: 2′,2′-difluorodeoxyuridine
Gemcitabine
HPLC
Ion-pair
Plasma
Issue Date: Oct-2003
Citation: Wang, L.-Z., Goh, B.-C., Lee, H.-S., Noordhuis, P., Peters, G.J. (2003-10). An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography. Therapeutic Drug Monitoring 25 (5) : 552-557. ScholarBank@NUS Repository.
Abstract: An expedient method is presented for determination in human plasma of gemcitabine and its metabolite 2′,2′-difluorodeoxyuridine (dFdU) by ion-pair reversed-phase HPLC. Samples were simply prepared by protein precipitation. Separation was processed on a Thermo Hypersil column (250 × 4.6 mm, 5 μm Hypersil® BDS C18) with UV detection at 272 nm. The mobile phase consisted of 17% methanol and 83% phosphate buffer (20 mM, pH 3.1) containing 10 mM sodium 1-heptanesulfonate with a flow rate of 0.8 mL/min. The lower limit of quantification (LLOQ) of gemcitabine was 0.08 μg/mL with linear response over the range 0.08-20.0 μg/mL, and LLOQ of dFdU was 0.1 μg/mL with linear response over the range 0.1-50.0 μg/mL. Assay accuracy for both compounds was within ± 4%. The coefficient of variation (CV %) for intra- and interday precision for both compounds was
Source Title: Therapeutic Drug Monitoring
URI: http://scholarbank.nus.edu.sg/handle/10635/105637
ISSN: 01634356
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.